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Abstract 
Problem: Opioid use and misuse is a leading cause of injury and death among adolescents and 
young adults in the United States, with a three-fold increase in opioid overdoses since 2000 
(Carney et al., 2018; Hudgins et al., 2019). Opioid misuse correlates with misuse of other 
substances, which exponentially increases health risks over time. The most effective treatment 
for opioid use disorder (OUD) among adolescence is through effective prevention interventions 
that either prevent the development of the OUD or enable timely diagnosis and treatment in 
order to prevent poor health outcomes. 
Context: The use of eHealth technology, which has been successfully used in the management 
of other chronic diseases, including hypertension and diabetes mellitus, is one proposed 
intervention to prevent OUD among youth and to connect them with treatment resources 
(Nuamah et al., 2020). This technology could be particularly useful among youth due to their 
familiarity with and affinity towards using technology in their everyday lives. Granite Wellness 
Centers (GWC), a drug and alcohol treatment organization in rural Northern California, 
received grant funding from The California Youth Opioid Response (YOR California), to 
design and develop an eHealth resource to address OUD among youth ages 12 years to 24 
years in rural Northern California communities (California Institute for Behavioral Health 
Solutions, 2015). This project sought to design and develop an eHealth resource and to conduct 
a pilot program.  
Interventions: A youth focus group and online survey were conducted to gather stakeholder 
data and input regarding the design for the eHealth drug resource. The stakeholder data 
informed the design and development of the GWConnect mobile app, to include culturally-
informed harm reduction tools, such as unbiased, evidence-based drug information; news 
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alerts; ask-a-provider feature; and local treatment resources. An 80-day pilot program was 
conducted to assess effectiveness of the app.  
Outcome Measures: A pre/post pilot survey was administered to assess change in youth 
knowledge of drugs, knowledge of local drug treatment resources, and the likelihood that youth 
would use the app to access information on drugs and local treatment resources. The surveys 
also assessed whether youth found the app to be effective in delivering the aforementioned 
content and their level of satisfaction with the app.   
Results: Through data analysis, results indicated a 26.47% increase in knowledge about drugs 
and a 20.32% increase in likelihood youth would use a mobile app to access information on 
drugs. Interestingly, even though the greatest increase was observed in knowledge of drug 
treatment resources and how to access them (45.83%), there was only a slight increase in the 
likelihood youth would use a mobile app to access information on treatment resources 
(14.09%). Overall, the pilot program participants were satisfied with GWConnect and found it 
to be effective.  
Conclusions: Increased knowledge can empower youth to make informed decisions preventing 
substance use disorder and/or reducing harm related to risky behaviors Increased knowledge of 
treatment resources can improve timeliness of treatment initiation and reduce harm associated 
with untreated substance use disorder. The overarching aim of GWConnect is to reduce the 
incidence of OUD and overdoses among rural youth in Northern California; therefore, future 
longitudinal research is needed to assess its effectiveness over a period of time. 
 Keywords: Opioid use disorder/OUD, prevention, treatment, youth, adolescents, mobile 
application, mobile app, app, eHealth resource, and eHealth technology. 
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Section II: Introduction 
Background 
The opioid class of drugs includes prescription pain relievers, such as oxycodone, 
hydrocodone, morphine, and codeine; synthetic opioids, such as fentanyl; and illicit opioids, such 
as heroin (National Institute on Drug Abuse, 2020). Initially, prescription opioids were mainly 
used to treat cancer pain and acute pain, dating back to 1911 (U.S. Food and Drug 
Administration (FDA), Center for Drug Evaluation and Research, 2021). 
Misuse of opioids refers to any use other than how they are prescribed or the use of illicit 
opioids in any way. Misuse of opioids increases the risk of overdose and death, and widespread 
misuse has results in an opioid overdose epidemic that has plagued the United States for over 
three decades (Centers for Disease Control and Prevention [CDC], 2021a). The opioid epidemic 
can be described by three distinct waves, periods of time in which significant spikes in opioid 
overdose deaths have been observed in the United States (CDC, 2021a).  
The first wave of the opioid epidemic in the United States occurred in the 1990s, when 
there was an increase in opioid prescriptions and an increase in overdose deaths involving 
prescription opioids (CDC, 2021a). Several events preceded and contributed to the first wave. In 
the 1980s, two small retrospective studies, published by the New England Journal of Medicine 
and the Pain Journal, reassured medical providers that it was safe to prescribe opioids more 
frequently (Jones et al., 2018). Pharmaceutical companies then aggressively marketed opioids as 
non-addictive (Jones et al., 2018). In 1996, pain was added as the fifth vital sign. As a result, 
there was an increased priority placed on assessing and treating pain thoroughly and in a timely 
manner (Levy et al., 2018). Consequently, the threshold for administering prescription opioids 
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for the treatment of pain was lowered, and medical professionals began prescribing opioids more 
frequently (Scalpel, 2016). 
The second wave occurred in 2010, approximately two decades after the first wave, when 
there was an increase in overdose deaths involving the illicit opioid heroin (CDC, 2021a). 
Decades of overprescribing opioids resulted in an increase in the number of people who 
developed a physical dependence to opioids, which would result in withdrawal symptoms if they 
stopped taking these medications (Jones et al., 2018). This opioid-dependent population also 
developed a higher tolerance over time that required more opioids to achieve the same effect. As 
a result, if unable to obtain enough prescription opioids to meet their physical dependence and 
prevent withdrawal symptoms, people began to seek out and use illicit opioids, such as heroin or 
any opioids obtained on the street without a prescription (CDC, 2021a). Consequently, there was 
an increase in heroin overdose deaths in 2010 (CDC, 2021a).  
The third wave occurred in 2013, a few years after the second wave, when there was an 
increase in overdose deaths involving synthetic opioids, particularly fentanyl (CDC, 2021a). The 
demand for fentanyl has remained high to the present day. Fentanyl is found in combination with 
other substances, rendering it exponentially more dangerous (CDC, 2021a).  
An opioid use disorder (OUD), encompassing misuse and abuse of opioids, is a high-risk 
behavior that has been noted to result in increased crime, utilization of health care services, and 
disease transmission, as well as lost productivity and strained personal relationships (Timko et 
al., 2016). There has been a significant societal impact related to the opioid crisis, in addition to 
the increased costs that society has absorbed due to lost employment, criminal justice utilization, 
healthcare services, and fatal opioid overdoses (Hagemeier, 2018). In 2015, it was estimated that 
the total annual economic burden of the opioid crisis was $504 billion (Hagemeier, 2018).  
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As well as the financial cost, OUD increases an individual’s morbidity and mortality risk 
by increasing the risk of drug overdose, cardiovascular disease, cancer, and infectious diseases, 
such as Hepatitis C (Hser et al., 2017). In the United States in 2016, there were 64,000 deaths 
due to drug overdoses, with 66% of those due to opioids (Jones et al., 2018). From 1999 to 2014, 
fatal opioid overdoses tripled among young people ages 15 years to 24 years (Saloner et al., 
2017). The U.S. Department of Health and Human Services (2019) classified the opioid 
epidemic as a public health emergency in 2017.  
The Problem: Adolescents and Opioid Use 
Substance use is often initiated during adolescence (National Institute on Drug Abuse, 
2020). From 1994 to 2007, the prescribing rates for prescription opioids among adolescents and 
young adults doubled (American Society of Addiction Medicine, 2016). However, adolescents in 
the United States are at high risk of being exposed to and becoming dependent upon opioids for 
many additional reasons, including, but not limited to, ready access, a developing and vulnerable 
state of mind, peer pressure, and engagement in risky behaviors (National Institute on Drug 
Abuse, 2020).  
Monitoring the Future study surveys a cross-sectional, nationally representative sample 
of high school seniors in the United States on an annual basis, and the prevalence data indicated 
that prescription opioid use increased steadily from 1976, with peaks in 1989 and 2002 and a 
brief decline from 2013 to 2015 (McCabe et al., 2017). Twenty-five percent of high school 
seniors reported opioid use (McCabe et al., 2017). Adolescents who reported non-medical opioid 
use indicated they initially started with medical opioid use (McCabe et al., 2017).  
In 2015 and 2016, The National Survey on Drug Use and Health revealed that in the 
United States, 21% of adolescents (12 years to 17 years) and 32% of young adults (18 years to 
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25 years) used prescription opioids in the past year, and 4% of adolescents and 8% of young 
adults misused opioids (Hudgins et al., 2019). In 2016, the prevalence of adolescents who 
misused opioids in California was 7%, which is 3% higher than the national average, with higher 
rates observed in rural California communities, primarily due to limited resources (Regents of 
the University of California, 2020).  
The National Institute on Drug Abuse for Teens (2019) reported that 57% of 12- to 17-
year-olds who misused prescription opioids got them from a friend or relative, while 20% of 12th 
graders said they could get heroin if they so desired. In 2015, 21,000 adolescents in the United 
States reported using heroin (American Society of Addiction Medicine, 2016). 
In 2015, 276,000 adolescents were using opioids for non-medical reasons, and 44% of 
those individuals were diagnosed with an addiction to opioids (American Society of Addiction 
Medicine, 2016). Opioid use and misuse is a leading cause of injury and death among 
adolescents and young adults in the United States (Hudgins et al., 2019). Most youth who misuse 
prescription opioids obtained them from a single prescriber, friends, or a family member. Opioid 
misuse also correlates with misuse of other substances, which exponentially increases health 
risks over time.  
Treatment programs that incorporate both pharmacotherapy and biopsychosocial 
interventions have proven to be the most effective treatment for opioid dependence (Jones et al., 
2018). The preferred treatment delivery method for anyone, adolescent or adult, with an OUD is 
medically-assisted treatment (MAT), because it takes a holistic approach by incorporating 
medication, behavioral therapy, and psychosocial supports, and it correlates with better patient 
outcomes (Timko et al., 2016). According to the Substance Abuse and Mental Health Services 
(SAMSHA, 2015), MAT programs have been shown to improve patient survival, increase 
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retention in treatment, decrease illicit opiate use, decrease criminal activity, increase ability to 
secure and maintain employment, improve birth outcomes for moms with OUD, decrease risk of 
contracting the human immunodeficiency virus (HIV) and Hepatitis C, and decrease risk of 
relapse.  
The opioid crisis has significantly impacted adolescents, with a three-fold increase in 
opioid overdoses since 2000 (Carney et al., 2018). However, only about 8.5% of adolescents 
with OUD receive treatment (Carney et al., 2018). Carney et al. (2018) presented treatment 
protocols for adolescents with OUD based upon evidence-based research. The medication aspect 
of MAT includes prescription medications approved by the FDA to treat OUD. These 
medications include buprenorphine/naloxone, methadone, and naltrexone.  
Buprenorphine is a partial opioid agonist that diminishes opioid withdrawal symptoms, 
reduces cravings, increases safety in the event of an opioid overdose, and has a low potential for 
misuse and diversion (SAMSHA, 2015). Buprenorphine is also available in combination with 
naloxone, the rescue medication used to treat opioid overdose. Methadone is a full opioid agonist 
that reduces opioid cravings and withdrawal symptoms and blocks the effects of opioids 
(SAMHSA, 2015). Naltrexone is a competitive opioid receptor antagonist that blocks the 
euphoric and sedative effects of opioids and reduces opioid cravings. Naltrexone is not addictive 
and does not cause withdrawal symptoms when it is discontinued (SAMHSA, 2015). Carney et 
al. (2018) recommended that primary care providers become familiar with the prescribing 
practices of these medications in order to better serve adolescents with OUD, especially in 
settings with limited resources, such as rural areas.  
The medications to treat OUD have been well-studied and approved for use in adults, but 
little research has been done on their use among youth because the prevalence of OUD among 
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youth has only recently been identified as a significant problem (Camenga et al., 2019). 
Camenga et al. (2019) conducted a literature review of 14 published works on methadone, 
buprenorphine, and naltrexone to obtain efficacy data among adolescents. They found that the 
risk of not treating OUD outweighs the risk associated with any of the medications.  
Chang et al. (2018) proposed treatment protocols for adolescents and young adults (15 
years to 25 years) with OUD based upon evidence-based research. Buprenorphine/naloxone is 
currently approved for use in 16-year-olds. Methadone can be prescribed under the age of 18 
years, but parental consent or evidence of failed abstinence or difficulty with withdrawing from 
opioids may be required (Chang et al., 2018). Buprenorphine/naloxone is safe for use among 
youth with OUD and should be considered first-line treatment. The American Academy of 
Pediatrics and other agencies have expressed their support of buprenorphine/naloxone and 
methadone for treatment of youth with OUD because the benefits of treating OUD with these 
medications appear to outweigh the risks of potential medication side effects (Chang et al., 
2018).  
Even though there is limited data to demonstrate efficacy of these medications in 
adolescents, anecdotal and practice-based evidence demonstrates better health outcomes (Chang 
et al., 2018). A recent study demonstrated that prolonged use of the aforementioned medications 
was effective in preventing relapse (Chang et al., 2018). Youth reported that buprenorphine/ 
naloxone was superior to methadone in reducing cravings and withdrawal symptoms (Chang et 
al., 2018).  
Another important factor youth reported was they perceived less stigma associated with 
buprenorphine/naloxone versus methadone. Stigma and shame are contributing factors as to why 
individuals with OUD do not seek treatment (Carson, 2019). Carson (2019) utilized theoretical 
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principles to better understand how medical providers may increase barriers to treatment for 
adolescents with OUD based upon their own unconscious biases. The article addresses the 
phenomena that many healthcare providers place a stigma on OUDs, which prevents them from 
discussing and initiating treatment, even life-saving measures such as naloxone. Medical 
providers ought to be aware of any unconscious biases they may have that can lead to 
stigmatizing OUD and that may have negative implications on their ability to discuss the realities 
of an OUD with their patients.  
Buprenorphine/naloxone can be prescribed by any approved provider in any setting; 
whereas, methadone must be prescribed, dispensed, and monitored with frequent follow-up visits 
by a methadone clinic (Chang et al., 2018). As a result of the findings in the Chang et al. (2018) 
study, the use of buprenorphine/naloxone is considered first-line treatment for adolescents with 
OUD; methadone is considered second-line treatment.  
Naltrexone is the third FDA-approved medication to treat OUD. Naltrexone carries a 
potentially serious side effect of increased risk of fatal overdose in the event of a relapse because 
the medication reduces one’s opioid tolerance. For example, if someone taking naltrexone 
relapses and uses the same amount of opioids they were accustomed to using prior to starting 
naltrexone, they could die from an unintentional fatal overdose due to their decreased opioid 
tolerance (Chang et al., 2018). Relapse is a common phase in the cycle of any chronic condition, 
including addiction; therefore, every person should receive extensive counseling on this potential 
side effect prior to starting the medication (American Addiction Centers, 2019). The extended-
release formulation of naltrexone may carry less risk of fatal overdose because it is released into 
the body at a slow rate; further studies are needed on its use among adolescents.  
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In addition to the medications, the psychosocial supports are the other aspect of MAT and 
are recommended during all stages of treatment (Chang et al., 2018). Psychosocial supports 
include various forms of individual, group, and/or family counseling and behavioral therapies.  
Feder et al. (2017) conducted an observational study and analyzed data from the 2013 
Treatment Episode Data Set to quantify adolescents’ current use of MAT. They found that about 
26% of adults in treatment for heroin addiction receive MAT services, compared to only about 
2% of adolescents. The reasons for adolescent underutilization of MAT are not well understood, 
because MAT has not been widely studied among adolescents, but patient, parent, and physician 
preferences are thought to be contributing factors (Feder et al., 2017). Another barrier is that, 
despite the dramatic rise in the prevalence of OUD among youth, medical providers, particularly 
pediatricians and primary care providers, have not received adequate training in addiction 
treatment and have not established connections within their communities to readily and 
efficiently refer patients to MAT programs (Feder et al., 2017).  
Hadland et al. (2018) reported that the initiation of medication to treat OUD at the time of 
diagnosis results in better health outcomes due to improved retention in treatment compared to 
the initiation of psychosocial interventions alone. The aforementioned medications approved to 
treat OUD primarily do so by reducing cravings and withdrawal symptoms and blocking or 
blunting the effects of opioids (SAMHSA, 2015). However, Hadland found that only 25% of 
young adults (18 years to 22 years) and only 4.5% of adolescents (18 years and younger) were 
prescribed medications to treat OUD at time of diagnosis. Adolescents are not receiving the full 
spectrum of OUD treatment.  
The most effective treatment for OUD among adolescents is through effective prevention 
interventions that either preclude the development of the OUD or enable timely diagnosis and 
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treatment in order to prevent poor health outcomes. Screening for risk factors during adolescence 
and taking steps to better understand social determinants of health is necessary to identify 
barriers that delay diagnosis and treatment, as well as treatment retention (Grubb, 2019). 
Education, or lack thereof, may be an important barrier to assess. Schepis et al. (2018) conducted 
a cross-sectional study utilizing data from the 2015 National Survey on Drug Use and Health and 
found that the highest rates of misuse were observed among individuals who were poorly 
engaged in school or not in school at all. Another barrier may be current policies that limit access 
or impose certain processes that make it difficult to gain access to proper evaluation and 
treatment; policy change is needed to expand access and facilitate ease of referral to MAT 
services for adolescents (Feder et al., 2017). This DNP project sought to research and develop an 
innovative harm reduction resource to address opioid use among youth in rural Northern 
California.  
Specific Aims 
The overarching aim is to reduce the incidence of OUD and overdose among rural youth 
in Northern California. The project goal is the development and implementation of an eHealth 
intervention by May 2021 that will provide culturally-informed harm reduction tools (e.g., 
unbiased drug information, Narcan information, news alerts, ask-a-provider feature, and referral 
resources) to reduce the prevalence of substance use disorder (SUD) and OUD among rural 
youth. The SMART (specific, measurable, achievable, realistic, and timely) objectives for the 
project are:  
1. Youth (12 years to 24 years) in Northern California will be more knowledgeable 
about drugs after having access to the GWConnect app for up to 80 days.  
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2. Youth will be more knowledgeable of drug treatment resources in Northern California 
and how to access them after having access to the app for up to 80 days.  
3. Youth will be more likely to use the app to access information on drugs and treatment 
resources in Northern California after having access to the app for up to 80 days. 
4. Youth will report a high level of satisfaction with the app after having access to it for 
up to 80 days. 
5. Youth will report that the app is effective in providing information on drugs and local 
resources after having access to it for up to 80 days.  
Available Knowledge 
PICOT Question 
The PICOT question is, among youth in a rural Northern California community (P), are 
eHealth interventions (I), compared to standard interventions (C), effective in increasing 
knowledge related to substance use/misuse and treatment options (O) within 80 days (T)? The 
summary of evidence is organized in an evaluation table in Appendix A.  
Search Process 
A comprehensive search of the available literature was performed using the databases 
PubMed, CINAHL, Scopus, PsychINFO, and Joanna Briggs. Search terms included opioid use 
disorder/OUD, prevention, treatment, youth, adolescents, mobile application, mobile app, app, 
eHealth resource, and eHealth technology. There are opioid abuse and dependence treatment 
guidelines in Dynamed for adults, but there are no specific guidelines for MAT among adults or 
youth. There were no systematic reviews on MAT for adults or youth in Cochrane. Journal 
articles were carefully selected for this manuscript based on the following search criteria: articles 
published within the past 6 years and articles in the English language.  
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Evidence Appraisal Tool 
The Johns Hopkins Nursing Evidenced-Based Practice Appraisal Tool was utilized to 
analyze the research (Dang & Dearholt, 2017). The research articles selected for this DNP 
project were appraised utilizing the Johns Hopkins Nursing Evidence-Based Practice Evidence 
Appraisal Tool (see Appendix A). This rating scale examines the strength of the evidence (e.g., 
Level I-V) and the quality of the evidence (e.g., high, good, or low).  
Literature Review 
eHealth Resource/Technology 
The use of eHealth technology is one proposed intervention to prevent OUD among 
youth and connect them with treatment resources and services (Nuamah et al., 2020). The terms 
mobile application, mobile app, app, eHealth resource, and eHealth technology all refer to a 
computer program or software that runs on mobile devices, including phones, tablets, and 
watches. This review will use the aforementioned terms interchangeably.  
There has been an increase in eHealth technologies related to drugs; however, the 
majority have been developed for use by medical providers as a reference tool for treatment 
guidelines and recommendations (Nuamah et al., 2020). Mobile technologies have been 
developed for and successfully used in the management of other chronic diseases, including 
sickle cell disease, hypertension, diabetes mellitus, and chronic obstructive pulmonary disease, to 
name a few (Nuamah et al., 2020). Designing and developing eHealth technologies specifically 
for the management of OUD could eliminate a barrier to MAT treatment by allowing the patient 
the ability to communicate with a medical provider, track his or her symptoms, and access 
evidence-based information and reliable resources related to OUD. This technology could be 
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particularly useful among youth due to their familiarity with and affinity towards using 
technology in their everyday lives.  
Cordova et al. (2018) assessed the usability and acceptability of a mobile health 
(mHealth) app among adolescents and its effect on health risk behaviors, specifically drug use, 
condomless sex, and STI/HIV testing. The study took a multiple-methods approach and 
purposive sampling of 30 adolescents (13 years to 22 years), predominantly African American 
and female, in Southeast Michigan. The mHealth preventive intervention was designed in 
collaboration with a youth leadership council. Quantitative and qualitative usage data of the 
mHealth resource were collected from July to September 2015. The adolescents were asked to 
fill out a demographic questionnaire and health risk behavior assessment questionnaire, test the 
mHealth resource on iPads, complete modules to assess usability, and participate in either a focus 
group or individual interview to discuss the overall experience. Pre-assessment data revealed that 
36% of adolescents self-reported illicit drug use within the past 90 days, and 71% of adolescents 
self-reported engaging in sexual activity within the past 90 days.  
The participants were asked the same open-ended questions about what they thought 
about the mHealth app, which aspects they liked or found useful, and what they would change, in 
both the post-assessment focus group and the individual interviews. The focus group and 
interviews were recorded, transcribed, and analyzed. Content analysis was utilized to organize 
the data into categories and themes for analysis. The quantitative data was collected via 
demographics questionnaire and health risk behavior questionnaire (0=no, 1=yes). Participants 
filled out a 13-item Session Evaluation Form (SEF) with Likert-type responses ranged from 1 for 
strongly agree to 5 for strongly disagree, and an 8-item Client Satisfaction Questionnaire (CSQ) 
with Likert-type responses ranged from 1 for poor to 5 for excellent. Descriptive statistics 
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analysis was used to analyze the demographic and health risk behavior data, and means and 
standard deviations were calculated to analyze the SEF and CSQ.  
Post-assessment data revealed adolescents reported high levels of usability and 
acceptability of the mHealth intervention. Adolescents found that the online risk assessment was 
a great way to initiate a conversation with their medical provider about sensitive subjects related 
to health risk behaviors. The mHealth resource provided access to information on drugs that 
adolescents found to be helpful, increased their knowledge, and gave them tools to use in order 
to make informed decisions. Overall, adolescents found the mHealth resource to be helpful in 
engaging them in preventing health risk behaviors, specifically related to drug use and sexual 
practices. This article is rated Level III and good quality according to the Johns Hopkins Nursing 
Evidence-Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017). 
Cordova et al. (2019) assessed feasibility and accessibility of Storytelling 4 
Empowerment (S4E), a mobile app aiming to prevent substance use and STI/HIV. This multi-
method study utilized community-based participatory research principles (CBPR) and design 
thinking to design an app that would engage both medical clinicians and youth. The S4E was 
designed, based upon community member input from youth, ages 13 to 22, and clinicians, as 
well as innovative approaches taken by the research team, to include a risk assessment tool, 
motivational interviewing language to facilitate risk behavior discussions, and referral resources.  
The use of S4E was evaluated among medical clinicians and youth, focusing on 
improving the communication between them, as well as reducing health risk behaviors among 
youth. Both youth and clinicians completed a demographic data survey at baseline. Youth also 
completed a baseline health risk behavior questionnaire that focused on drug use and sexual 
activity. Youth were asked direct questions about STI and HIV testing prior to and after 
DEVELOPMENT OF AN EHEALTH HARM REDUCTION RESOURCE  20 
 
interfacing with S4E. Youth and clinicians were asked questions with Likert-type response 
regarding their experience with S4E related to communication between youth and clinician. 
Clinicians also completed a post-intervention satisfaction and acceptability survey.  
Descriptive statistical analysis was utilized to describe the participants. The pre-
intervention STI and HIV testing data was compared to the data collected post-intervention. 
Means were calculated in order to analyze the clinician satisfaction and acceptability survey. 
Qualitative post-intervention data was collected during youth and clinician interviews through a 
series of open-ended questions assessing overall experience and satisfaction. The interviews are 
recorded and transcribed. Content analysis categorized the data into themes.  
The data suggested that S4E facilitated prevention approaches to reduce health risk 
behaviors, increased STI/HIV knowledge and testing, as well as communication between youth 
and clinicians. High levels of feasibility and acceptability were reported by both the clinicians 
and the youth. This article is rated Level III and good quality according to the Johns Hopkins 
Nursing Evidence-Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017). 
Cordova et al. (2020) stated that mHealth technology can be used to prevent and reduce 
health risk behaviors (e.g., substance use and unsafe sexual practices) among adolescents. S4E 
was evaluated for its effect on health behavior change among youth. S4E consists of three 
interactive online modules on alcohol and drug use and STI/HIV. Fifty youth, ages 13 to 21, 
were randomized to either the S4E arm or the standard care arm, with a pre-assessment, post-
assessment, and a 30-day post-assessment.  
Youth and clinicians completed a baseline demographics survey, and then a questionnaire 
with Likert-type responses following their interaction to assess their communication, language, 
and actions taken regarding health risk behavior services. Youth refusal skills regarding 
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substance use were assessed through two questions with responses on a scale of 1 for very hard 
to 4 for not very hard. Sexual risk behavior refusal skills were assessed through one question 
with responses on a scale of 1 for strongly disagree to 5 for strongly agree. Youth substance use 
and sexual risk prevention knowledge was assessed through four questions with an agreement 
scale. Finally, youth behaviors regarding substance use, sexual risk, and HIV/STI testing were 
assessed through yes and no answers, where 1 was used for yes and 0 was used for no.   
Descriptive statistical analysis was utilized to analyze baseline data and any differences 
between the S4E arm and the standard care arm. Chi-square tests and 2-tailed t tests analyzed 
differences between the groups from the start of the study to the 30-day follow-up evaluation. 
Post-intervention changes regarding reported substance use, sexual risk behaviors, and STI/HIV 
testing were compared between the groups.  
Randomization was successful in this study as there were no differences between groups 
at baseline. There no differences between the groups in either attrition (P=.92) or number of days 
to follow-up (P=.68). The S4E youth reported more risk communication with the clinicians 
(P=.58). The S4E clinicians also reported more risk communication with the youth (P=.45). The 
S4E youth reported a greater change in refusal skills for alcohol (P=0.67) and drugs (P=0.68). 
The S4E youth also reported greater change in prevention knowledge regarding sexual risk 
(P=.60) and STI/HIV (P=.34). There was not a significant change in reported substance use 
from baseline. The S4E group reported increased STI/HIV testing (P=.57). 
Youth in the S4E arm demonstrated a reduction in health risk behaviors over the past 30 
days, including substance use, as well as increased knowledge of prevention strategies. mHealth 
technology can be utilized to reduce substance use and other health risk behaviors among youth. 
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This article is rated Level I and good quality according to the Johns Hopkins Nursing Evidence-
Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017). 
Scheier et al. (2019) gathered stakeholder input on the design of an online, family-based 
drug prevention program called Strengthening Families Program (SFP). The in-person format 
has proven to be effective in preventing youth drug and alcohol use, but that delivery method 
requires a lot of resources. This mixed-methods study was a Phase I National Institute of Health 
funded Small Business Innovative Research Grant. The study engaged subject-matter experts and 
stakeholders in the design of the online SFP delivery. They conducted interviews with prevention 
and online learning experts and family services personnel. They also surveyed and conducted 10 
focus groups with 85 adults.  
A subject matter expert panel was convened, including five prevention scientists and five 
e-learning experts, for a teleconference interview. The subject matter experts answered questions 
regarding the feasibility of SFP online, its features, and how to implement it. Parents completed 
consumer preference surveys containing questions with either yes or no responses or Likert-type 
responses. The focus groups were recorded and transcribed for thematic analysis.  
The principal findings of the thematic analysis revealed that the online program should 
include the drug prevention content in an interactive and engaging manner. There was an 
emphasis placed on brief skills-oriented sessions, graphics over text, animation, real-life role 
play scenarios, connection with agency personnel who can monitor progress, and printable 
materials to work on at home. This study informed the design and development of curriculum for 
an online, family-based drug prevention program based upon what the family wants to learn, in 
the preferred delivery format, and with features that facilitate engagement and retention. This 
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article is rated Level III and good quality according to the Johns Hopkins Nursing Evidence-
Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017). 
Schuman-Olivier et al. (2018) assessed the feasibility, usability, and acceptability of 
MySafeRx, a mobile resource developed to promote buprenorphine/naloxone treatment 
adherence. They conducted a 28-day, single-arm, observational study of the use of MySafeRx 
resource among early adults (18 years to 39 years) receiving buprenorphine/naloxone (B/N) for 
treatment of OUD. The MySafeRx technology incorporates motivational mentorship, ability to 
message your medical provider, and medication monitoring. The MySafeRx technology includes 
a secure electronic medication organizer that the app can unlock, text messaging with the 
treatment program, daily videoconference with a trained mobile recovery coach utilizing 
motivational interventions, and supervised medication self-administration via videoconference.  
The study began with an in-person training on the use of MySafeRx technology. The 
study participants attended a daily videoconference with a trained mobile recovery coach, 
completed weekly surveys regarding feasibility, usability, and acceptability, as well as weekly 
urine toxicology screenings during the 28-day study and for an additional 4-weeks post-
intervention.  
Study participants completed a baseline survey about demographics, substance use 
history, and technology use. Supervised medication self-administration through 
videoconferencing and medication adherence surveys assessed app feasibility. The initial in-
person training and a post-intervention survey assessed app usability. A weekly satisfaction 
survey, a post-intervention satisfaction survey, and urine toxicology screening assessed app 
acceptability.   
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Descriptive data analysis was utilized. In terms of feasibility, two-thirds of participants 
completed supervised medication self-administration 5 or more days per week and 83% self-
reported medication adherence. The in-person training resulted in high levels of user competency 
and the post-intervention survey demonstrated an average system usability score of 78.8. The 
satisfaction surveys revealed overall satisfaction with the pill dispenser, videoconference, and 
text messaging, and 75% of the participants expressed interest in continuing to use MySafeRx. 
The urine toxicology results demonstrated a 41.7% average level of illicit opioid abstinence 
during the first week of the study which increased to 63.6% during weeks three and four.        
Illicit opioid abstinence increased by 53% during the 28-day trial period. Participants 
reported good levels of usability and acceptability of the MySafeRx technology. The MySafeRx, 
or other similar mobile technology, can be used to increase adherence to OUD treatment. This 
article is rated Level III and good quality according to the Johns Hopkins Nursing Evidence-
Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017). 
Rationale 
Conceptual Framework 
The conceptual framework that guided this project was the social ecological model 
(SEM). Urie Bronfenbrenner introduced the SEM as a conceptual framework in the 1970s, and it 
was later adapted into a theory in the 1980s (Kilanowski, 2017). Using the SEM helps describe 
the interconnectedness of individual, relationship, community, and societal factors, and how they 
influence health behaviors (CDC, 2021b). The individual is at the center of this model; the next 
layer includes relationships which are the microsystem that has the most impact on the individual 
(Kilanowski, 2017). Then, there is the community which is the mesosystem that includes work, 
school, church, and neighborhood (Kilanowski, 2017). Finally, there are societal factors, 
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including social networks, which account for the exosystem that indirectly influences the 
individual (Kilanowski, 2017). A successful intervention will address all SEM levels in order to 
truly impact health behavior and create change (CDC, 2021b). 
The opioid crisis has persisted for several decades within the United States, and most 
efforts to thwart its progression have been directed towards adults with OUD. On average, most 
people who use or misuse drugs had their first encounter with drugs at 12- to 13-years old; 
however, few interventions target this age group (Natural High, 2020). My team wanted to tailor 
this eHealth resource to youth because significant efforts have not been made to update and 
deliver drug prevention and treatment initiatives that are relevant to today’s youth population in 
order to address this issue at time of onset.  
The Granite Wellness Center Youth Resiliency Program (GWCYRP), which encompasses 
my project, is trying to create change by developing and delivering preventive and treatment 
strategies specific to youth with OUD within the community that is affected by this problem. On 
the individual level, my project sought to become acquainted with our primary stakeholders via a 
focus group and an online survey to gain a deeper understanding of their beliefs and attitudes 
towards substance use, misuse, and treatment. That information has driven the design and 
development of the eHealth technology from the beginning. On the relationship level, we 
discussed how relationships influence behavior, and we learned that our primary stakeholders 
were seeking peer connection and support when looking for information on substance use, 
misuse, and treatment. As a result, we enabled a feature in the mobile eHealth resource called 
GWConnect (Granite Wellness Connect) to allow for peer-to-peer connection and 
communication. On the community level, we collaborated with experts in harm reduction in 
order to best communicate with our stakeholders. We received contributions from local artists to 
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improve the aesthetic of the app, and we communicated with other local drug and alcohol 
facilities to build a database of available services in the local area. On the societal level, we 
wanted to create an eHealth resource that was customized to our primary stakeholders in Nevada 
and Placer Counties. We also wanted GWConnect to be available to anyone looking for such a 
resource, whether a young person in need of information on drugs or a medical provider in need 
of a tool to engage a young person in drug treatment. Therefore, GWConnect will be readily 
accessible to anyone who has access to the Google and Apple stores. Essentially, anyone can use 
and may benefit from the app, and other communities can utilize it to engage with their youth 
population.  
Harm reduction principles also guided this project. The concept of harm reduction is to 
reduce the deleterious effects of health behaviors without completely eliminating the health 
behavior itself (Hawk et al., 2017). Hawk et al. (2017) defined six principles of harm reduction:  
1. Humanism refers to the fact that every individual deserves respect and dignity, and 
there is an understanding that harmful health behaviors also benefit the individual in 
some way, so it is of value to assess both the harm(s) and the benefit(s) in order to 
gain a better understanding as to why individuals make certain decisions. 
2. Pragmatism refers to the fact that perfection is not attainable, even when it comes to 
health behaviors, and social and environmental factors influence behavior, and 
therefore, should be taken into account to better understand the underpinnings of the 
behavior.  
3. Individualism refers to the fact that every person has his/her own needs and strengths, 
and it is essential to tailor intervention options in order to find the best fit for the 
individual at that particular time in his/her life. 
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4. Autonomy refers to the fact individuals make health decisions for themselves, and 
medical providers should provide information that empowers the individual to make 
an informed decision. 
5. Incrementalism refers to the fact that any positive change, no matter how small, can 
improve health, with the understanding that one can plateau or even regress 
throughout this process.  
6. Accountability without termination refers to the fact that individuals are accountable 
for their actions, and medical providers can help them understand their actions and 
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Section III. Methods 
Context 
There is an unmet need to provide youth with access to culturally-informed harm 
reduction tools in order to reduce the incidence of OUD. Providing youth with unbiased drug 
information, Narcan information, news alerts, ask-a-provider feature, and referral resources can 
increase knowledge and informed decision-making and reduce barriers to treatment access. An 
eHealth resource is the ideal means to deliver this information to youth, given their avid use of, 
familiarity with, and ready access to this technology (see Appendix B. Gap Analysis).  
The Organization: Granite Wellness Centers 
This project was completed at Granite Wellness Centers (GWC). Formerly known as 
Community Recovery Resources, GWC is a nonprofit 501(c)(3) corporation that has been 
providing drug and alcohol treatment in Northern California since 1974 (GWC, 2021). The GWC 
has six locations throughout Nevada and Placer Counties and employs 165 staff members (GWC, 
2021). The GWC has an annual operating budget of approximately $10 million. Funding sources 
include local, state, and federal grants, as well as donations and contributions (GWC, 2021).  
The GWC’s (2021) mission statement is to promote wellness and quality of life. They 
provide drug and alcohol treatment in inpatient and outpatient settings, MAT, detoxification, 
driving under the influence classes, transitional housing, treatment for adolescents, services for 
parents and families, life skills and wellness, and drug testing services (GWC, 2021). The 
majority of these services are for adults, 18 years and older, unless specifically identified as 
adolescent services. The GWC is actively working towards expanding services for adolescents.  
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Granite Wellness Centers Youth Resiliency Project 
The California Youth Opioid Response (YOR California) awarded GWC with a $500,000 
grant to fund GWCYRP. The purpose of the GWCYRP is to develop and deliver a system of care 
that addresses OUDs among young people. The values for the GWCYRP are “respect, cultural 
humility, innovation, partnership, and integrity” (California Institute for Behavioral Health 
Solutions, 2015, p. 1). The target population for this project is young people ages 12 years to 24 
years in rural Nevada and Placer Counties. This DNP project was one of the many projects under 
the GWCYRP umbrella. 
The California Youth Opioid Response (YOR) team developed an implementation plan 
consisting of six goals to direct the grant recipients’ use of the funds. My project is specifically 
involved in Goal 5, which states, “Prevent opioid misuse, abuse and overdose deaths, and reduce 
use of opioids among youth ages 12-24 with the development of culturally-informed, youth 
sensitive clinical services available on a drop-in, confidential basis” (California Institute for 
Behavioral Health Solutions, 2015, p. 2). The objective for Goal 5 is as follows,  
Utilizing a Positive Youth Development Framework, develop and implement culturally 
and trauma informed youth sensitive clinical services focused on behavioral health issues. 
GWCYRP adolescent health clinical services will address the critical components of 
youth sensitive services, including: accessibility, confidentiality, availability of providers 
specifically trained in adolescent health care, use of an innovative, nontraditional health 
care setting in a safe environment, and the implementation of eHealth technologies 
(California Institute for Behavioral Health Solutions, 2015, p. 2). 
There are many community-based organizations that are stakeholders in GWCYRP and 
support the implementation plan in various capacities, to include, the Coalition for Auburn 
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Youth, the Coalition for Nevada County Youth, Chapa De Indian Health, Sierra Care Pediatrics, 
Nevada County Health and Human Services, Placer County Health and Human Services, Placer 
Nevada Rx Safety Coalition, Idea Consulting, Youth from Nevada Union High School, Nevada 
County Superintendent of Schools Tobacco Use Prevention Education, Placer County Office of 
Education, and multiple regional school districts (California Institute for Behavioral Health 
Solutions, 2015).  
Interventions 
The DNP student was a member of the GWConnect team, which consisted of the grant 
principal investigator, software engineer, youth coordinator, app designer, lead app developer, 
and a public health expert. The team conducted in-person focus group and online survey (due to 
COVID-19 restrictions) to assess the needs of our primary stakeholders. Invitations to attend the 
focus group were sent to high schools in Nevada and Placer Counties, and the online survey was 
advertised via social media. The focus group included 15 participants and the online survey had 
28 respondents. The focus group and online survey data informed the design and development of 
the eHealth drug resource.  
The DNP student contributed to the design and development of the eHealth drug resource 
by building an evidence-based drug dataset and recording a guided body scan for inclusion in the 
app. The DNP student also conducted a pilot project, in which youth in Nevada and Placer 
Counties were given access to the app for 80 days and asked to complete pre- and post-surveys 
assessing knowledge of drugs and local treatment resources. The pilot project had 29 
participants. The pre-survey results reveal limited knowledge of evidence-based information on 
drugs and available treatment resources, resulting in an underserved adolescent population with 
OUD or at risk of developing an OUD. 
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Gap Analysis 
A gap analysis was conducted for this DNP project to assess the current state of this issue, 
the desired state, and the action needed (see Appendix B). An individual risk factor for youth 
substance use has been cited as a deficiency of knowledge regarding drugs and risk of use 
(Griffin & Botvin, 2010). The current state is limited knowledge of evidence-based information 
on drugs and available treatment resources, resulting in an underserved adolescent population 
with an OUD or at risk of developing an OUD. The desired state is access to evidence-based 
information on drugs and available treatment resources within a rural Northern California 
community in order to improve knowledge about drugs and use/misuse, as well as awareness of 
and how to access the available treatment resources within the local area. The action needed is to 
design and develop an eHealth drug resource specifically for the adolescent population within 
this rural Northern California community, publish it to the Google and Apple store for free 
download, and incorporate it into treatment protocols for youth with OUD at GWC.   
GANTT Chart 
A GANTT chart was utilized to outline the DNP project timeline from June 2020 to May 
2021 (see Appendix C). A literature review was conducted regarding the use of eHealth 
resources to prevent and treat OUD among youth. The DNP committee, consisting of the 
committee chair and second reader, was assembled. Meetings between the DNP student, 
committee chair, and the GWConnect team were conducted. A focus group and an online survey 
of the primary stakeholders, youth 12 years to 24 years in Nevada and Placer Counties, were 
conducted. The data from the focus group and online survey informed the design and 
development of the app, which occurred from September to December 2020. The DNP student 
organized and conducted a GWConnect pilot program from January to April 2021. Youth in 
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Nevada and Placer Counties were given access to the app for 80 days and asked to fill out online 
surveys prior to and following testing of the app. The survey data were collected and analyzed 
from February to May 2021. The DNP project write-up began in January 2021 and was 
completed by May 2021. The paper was disseminated to the committee chair and the second 
reader, and final edits were made. The DNP project was presented to University of San Francisco 
faculty and students in May 2021.  
Work Breakdown Structure 
Project details are outlined in a work breakdown structure (WBS; see Appendix D). The 
development of an eHealth harm reduction resource occurred in five phases: design, plan, 
intervention, results and evaluation.  
During the design phase, the scope of the project was developed. A gap analysis was 
completed based upon a thorough literature review and a needs assessment specific to GWC in 
Grass Valley. Based on the gap analysis, project objectives were developed. Key stakeholders 
were identified. The DNP student met with the key stakeholders to better understand the vision, 
mission, and goals for GWC and for this project. A project charter was developed and submitted 
to the DNP chair for review.   
During the plan phase, the GWConnect team was identified, with a discussion of roles. A 
project plan and the WBS were developed. The focus group questionnaire and surveys were 
developed and finalized.  
During the intervention phase, the focus group and initial online survey were conducted 
to gather data from the primary stakeholders that would inform the design and development of 
the app. The data were analyzed and the GWConnect app was designed and developed. The DNP 
student researched and built an evidence-based drug data set and collaborated with personnel 
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familiar with harm reduction principles in order to tailor the data set to the primary stakeholders. 
The DNP student also recorded a guided body scan for inclusion in the GWConnect app. The 
DNP student conducted an app pilot program of the app and administered pre- and post-testing 
surveys.  
During the results phase, the survey findings were analyzed. The findings were 
summarized and recommendations written. The evaluation phase consisted of reviewing 
feedback from surveys and verifying that recommendations align, writing the final report, 
submitting the DNP paper, and presenting the project to the University of San Francisco staff. 
Communication Matrix 
Communication between all members of the GWConnect team and all stakeholders in the 
DNP project was critical throughout every stage of this project. The DNP student maintained 
direct communication throughout the entirety of this project with the committee chair via Zoom 
and email. The GWConnect team communicated on a regular basis via email, Zoom, team 
Dashboard account, and team Slack channel. A GWConnect webpage was created as a resource 
for the pilot program participants, which contained background information on the app and 
contact information for any questions. A communication matrix was created for the DNP project 
(see Appendix E).  
Strengths, Weaknesses, Opportunities, and Threats  
An analysis of the strengths, weakness, opportunities, and threats (SWOT) was conducted 
(see Appendix F). 
Strengths 
The vast majority of youth are familiar with and have ready access to mobile 
technologies. Youth usually have some sort of mobile technology with them most of the time, 
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making a mobile app an ideal intervention to use in this population. A main strength of this 
project is that mobile technologies have been successfully used to prevent and manage other 
chronic diseases. During the COVID-19 pandemic, people have become more reliant on mobile 
technologies to connect virtually due to limitations on in-person interactions. Another strength of 
this project is that increased knowledge can facilitate informed decision-making for youth that 
can prevent OUD. The app design and development were based on primary stakeholder data 
obtained via focus group and online survey; the app was designed and developed specifically for 
youth 12 years to 24 years in Nevada and Placer Counties. Finally, the app was funded through 
the YOR California grant, and the project had buy-in from the GWC administration. 
Weaknesses 
The fact that the app was designed and developed for youth 12 to 24 years in Nevada and 
Placer Counties is both a strength and a weakness, because youth in other counties may not find 
it applicable to them. A main weakness of this project is the ability to connect with youth and 
have them download the app, and then to keep them engaged so they will continue to use it. The 
app requires a medical provider to answer any questions asked, requiring frequent monitoring of 
the app in order to provide a timely response. The app also requires updates regarding news 
related to drugs, substance use, and warnings in the local area. Another weakness of this project 
is that the app will require continuous updates to remain compatible with Android and iOS 
operating systems. Finally, there are costs associated with maintaining and updating the app over 
time.  
Opportunities 
Initial research revealed that there is no comparable product currently available on the 
market. Primary stakeholders reported what they were looking for in an eHealth resource through 
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the focus group and online survey, which gave the team the opportunity to design and develop 
the app specifically for the primary stakeholders. This project creates an opportunity to connect 
with youth in a medium they prefer, are familiar with, and have ready access to. This project also 
offers the ability to remain connected with youth, even during the COVID-19 pandemic when in-
person interactions are limited. Youth will have the opportunity to access evidenced-based 
information on drugs and treatment resources and to ask a medical provider questions in a 
secure, confidential, and non-confrontational manner. This project will dispel common myths 
about drugs and drug use. This project will prevent OUD among youth in Northern California. 
Threats 
One threat is app buy-in by youth. Youth may have a fear that their parents/guardians or 
the app administrator(s) are monitoring their activity, and simply accessing drug information 
could be perceived as thinking about or actually using drugs. Another threat is parents/guardians 
having a misperception that allowing youth to access information will make them more apt to 
use drugs. There is also concern that the YOR California grant funding may not be renewed. 
Overall, the strengths outweigh the weaknesses of this program. Based on the SWOT analysis, 
the program is feasible completed. 
Budget 
The proforma for this project is forecasted for 3 years and accounts for changing 
expenses over the life of the program, with a 3% increase in Year 2 and Year 3 over the previous 
year (see Appendix G). The YOR California, funded by the California Department of Health 
Care Services (DHCS), awarded 22 grants totaling $11 million in order to address OUD among 
youth ages 12 years to 24 years in rural Northern California communities (California Institute of 
Behavioral Health, 2015). In 2020, GWC received a $500,000 grant and allocated the funds to 
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the GWCYRP, $25,000 of which funded the design and development of the eHealth resource. 
The DHCS renewed the funds in 2021, securing this grant as a reliable funding source. 
GWC (2021) is a nonprofit 501(c)(3) corporation; therefore, there are no deductions from 
revenue. The 2016 and 2017 tax returns (Form 990) filed by GWC (formerly known as 
Community Recovery Resources or CoRR) were reviewed, and it was verified that there were no 
deductions from revenue.  
The youth focus group was conducted at GWC and there were no associated fees. The 
youth online survey was generated and distributed online at no charge. The initial $25,000 grant 
funds covered the cost of hiring an app designer and an app developer and the fees associated 
with registering the app with Google (one-time $25 fee) and Apple ($99 annual fee) app stores. 
The app will be available as a free download for users.  
The pre- and post-pilot surveys were generated through Qualtrics for free and distributed 
via email. All participants who completed the pilot program, including and the pre- and post-
surveys, were given $5 Amazon ecards, totaling $60. The DNP student used personal funds to 
finance the Amazon gift card incentive. Additional supplies included printouts/handouts and 
pens; the budget for supplies was $100 in the first year ($60 for Amazon ecards and $40 for 
printouts/handouts and pens). 
A part-time nurse practitioner and part-time app developer will regularly interact with the 
app, chat with users, answer questions posted, upload current events and warnings related to 
drugs, and schedule software updates, as needed, to ensure ease of use and accessibility. A 
portion of the 2021 grant funds are earmarked to cover the costs associated with maintaining and 
updating the app.  
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Return on Investment 
According to Salary.com (2021a, 2021b), the average nurse practitioner salary in Nevada 
County, California is $113,473 (range $105,481 to $123,487), and the average salary for an app 
developer in California is $73,973 (range $66,158 to $84,378). The total wages are $81,737 in 
Year 1, $95,426 in Year 2, and $98,288 in Year 3. The employees are independent contractors 
who do not receive benefits. The total expenses are $81,837 in Year 1, $95,529 in Year 2, and 
$98,394 in Year 3. The revenue less expenses is in the green for all 3 years: $418,163 in Year 1, 
$419,471 in Year 2, and $432,056 in Year 3. 
A return on investment (ROI) can be calculated for this project. Society will get a return 
on their investment in the form of significant cost savings and expense avoidance through 
GWConnect (see Appendix H). The long-term goal of GWConnect is that youth in Northern 
California will access it and report increased knowledge of drugs, which will result in decreased 
incidence of SUD among this population and, as a corollary, prevention of nonfatal and fatal 
overdoses.   
The societal cost of opioid addiction per person can be calculated by totaling the 
associated healthcare, law enforcement, and legal costs (Florence et al., 2016). The total societal 
cost of nonfatal OUD was $57 billion. This number can be divided by the number of people with 
an OUD in 2013 (1.9 million), resulting in a societal cost of $30,000 per person per year for 
nonfatal OUDs. The total cost of fatal opioid overdoses was $21.5 billion, divided by 16,235 
deaths due to fatal opioid overdose in 2013, equates to a societal cost of $1.3 million per fatal 
opioid overdose. The societal cost savings of one avoided fatal overdose is $1.3 million. There 
are an average of 136 fatal opioid overdoses per day, resulting in a potential cost savings of 
$176.8 million ($1.3 million multiplied by 136; CDC, 2021).  
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To calculate the ROI, the cost of designing, developing and distributing GWConnect 
($81,837) is subtracted from the cost savings of just one avoided fatal overdose ($1.3 million) 
and divided by the cost ($81,837) to equal 14.89. The ROI for this project, in the form of 
societal cost savings and expense avoidance, is 1,489%! That is a significant ROI, making this 
project fiscally sound and worthwhile.  
Study of the Intervention 
This DNP project aimed to design and develop an eHealth technology, GWConnect, for 
youth to increase awareness and knowledge of drugs and their effects, risks associated with 
substance use, and local resources available for SUD evaluation and treatment, within the 
context of harm reduction principles. An in-person focus group and an online survey (due to 
COVID-19 restrictions) were conducted to assess the needs of our primary stakeholders. The 
data collected informed the design of the GWConnect.  
The GWConnect pilot program was conducted to evaluate its effectiveness in achieving 
the aforementioned short-term goals among the primary stakeholders. Pre- and post-pilot 
program surveys were administered to all study participants. Survey data were collected and 
analyzed using Qualtrics. The data findings were presented to the GWConnect team and used to 
update GWConnect prior to launching in Google and Apple stores, as well as to inform future 
app updates.  
The long-term goal of GWConnect is that youth in Northern California will access it 
and report increased knowledge of drugs, which will result in decreased incidence of SUD 
among this population. Another long-term goal of this project is that youth will access the 
mobile app and report increased knowledge of local drug treatment resources, resulting in early 
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diagnosis of SUD and timely entry into treatment in order to improve long-term health 
outcomes. A longitudinal study is needed to assess the long-term outcome measures.  
Outcome Measures 
The outcome measures for this DNP project were to work with the GWConnect team to 
conduct primary stakeholder in-person focus group and online survey, contribute to the design 
and development of GWConnect, conduct a pilot program including pre- and post-assessment 
surveys, analyze pilot program data, and create a final presentation with recommendations for 
future updates to GWConnect.  
The GWConnect team conducted a focus group of our primary stakeholders during the 
initial planning phase in order to gain a better understanding of what youth were looking for in 
an eHealth drug resource. An advertisement seeking focus group volunteers was distributed to 
the local high schools in Nevada and Placer Counties. Inclusion criteria was anyone aged 12 
years to 24 years old residing in Nevada or Placer Counties. There were 15 respondents (eight 
females and seven males) who attended the focus group. Youth were asked what features should 
be included in this app, if there were any other similar resources on the market they find helpful, 
the language that should be used, how it should be marketed, and any other advice they would 
like to offer.  
The survey was advertised online via social media. Inclusion criteria was anyone 12 years 
to 24 years old residing in the United States; there were 28 respondents. The survey attempted to 
gather basic information for a general persona of our primary stakeholders, information that 
should be included in the drug info guide, how an interactive map of local resources should look, 
how information should be presented (e.g., text, illustration, video, audio), the ideal aesthetic for 
the app, and any other input the participant would like to contribute. 
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The survey collected demographic data, including age and gender. The survey attempted 
to get to know the primary stakeholders better through the following questions: What apps do 
you use most? Who are the most creative or interesting people you follow on Instagram (name at 
least three)? What’s a brand or online store you think is particularly cool? Where do you hear 
about the news? What’s your favorite way to learn new things? The survey assessed commonly 
used drugs among youth in a non-confrontational manner by asking the following question: 
What do you think are the most frequently used drugs among your friends and classmates? The 
survey assessed how informed youth were about drugs, their use, and their effects according to a 
scale of 0 to 10, in which 0 was not informed at all and 10 was very informed. The survey 
assessed if youth have ever looked for or asked someone for information about drugs and their 
effects, and if so, where did they look and/or who did they ask? The survey assessed if there is 
information that they would like to ask about drugs, but they are unsure how to ask or where to 
find the answer. The survey asked the respondents to rank the following drug information in 
order of importance: scientific names, street names, photos, precautions and safety for use, 
effects, duration of effects, risks, interactions with other substances, likelihood of addiction, how 
to test a substance for safety, antidotes/reversal agents, personal experiences, and an Other free-
text answer. The survey assessed for any fears related to drugs. Finally, the survey asked if they 
have come across and/or used any drug or alcohol-related resources that they found particularly 
helpful.  
The DNP student conducted a review of evidence-based resources to build a drug 
information database. The drugs included in the database were cocaine, heroin, inhalants, 
lysergic acid diethylamide (LSD), marijuana, 3,4-methylenedioxy methamphetamine (MDMA), 
methamphetamine, phencyclidine (PCP), synthetic cannabinoids, synthetic cathinones, tobacco, 
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alcohol, prescription central nervous system depressants, prescription opioids, prescription 
stimulants, prescription anabolic steroids, over-the-counter (OTC) dextromethorphan, and OTC 
loperamide. The database included information on drugs, including commercial names, street 
names, a brief description of the drug, common forms, common ways the drug is taken, the Drug 
Enforcement Administration schedule/classification, short- and long-term effects, other health-
related issues, withdrawal symptoms, and treatment options, including medications and 
behavioral therapies. One of the recurrent themes of the focus group and initial online survey 
was the importance of incorporating mindfulness components, such as meditations and body 
scans, into this app. Therefore, the DNP student also researched and recorded a 6-minute guided 
body scan meditation for inclusion in the app. 
The GWConnect app pilot program was conducted from March to May 2021. Inclusion 
criteria was anyone 12 years to 24 years residing in Nevada and Placer Counties. The completion 
of a pre- and post-survey was required. The survey collected demographic data, including state 
and county of residence, age, gender, possession of mobile device, the operating system of their 
device, and email address. An email invitation was sent to each participant containing a unique 
code to download GWConnect. The participants were given access to the app for up to 80 days 
and were instructed to peruse all the features and take notes in real-time in order to provide 
feedback in the post-pilot survey.  
The pre-pilot survey (Appendix I) assessed baseline knowledge of drugs and local drug 
treatment resources through the following two questions: How knowledgeable do you feel about 
drugs? If you or someone you know needed help for drug use/misuse, how knowledgeable are 
you regarding where resources are in your local area and how to access them? Likert-type 
responses ranged from 1 for not knowledgeable at all to 5 for extremely knowledgeable. The 
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survey assessed baseline likelihood that youth would use the app to access information on drugs 
and local treatment resources through the following questions: How likely are you to use a 
mobile app to access information on drugs? How likely are you to use a mobile app to access 
information on treatment resources in your local area? Likert-type responses ranged from 1 for 
extremely unlikely to 5 for extremely likely. The final question allowed multiples answers and 
asked: What features are important to include in a mobile app containing information on drugs 
and related resources? The answer choices included drug facts and figures, treatment resources, 
mindfulness activities, education on Narcan, warnings related to drug use in your community 
(e.g., uptick in fentanyl overdoses), ability to chat with and ask a medical provider questions, 
Q&A Forum, and a free-text option.  
The post-pilot survey (see Appendix J) assessed for any changes in knowledge of drugs 
and local drug treatment resources, after having access to GWConnect for up to 80 days, through 
the following two questions: After beta testing the Granite Connects app, how knowledgeable do 
you feel about drugs? After beta testing the Granite Connects app, how knowledgeable are you 
regarding drug treatment resources are in your local area and how to access them? Likert-type 
responses ranged from 1 for not knowledgeable at all to 5 for extremely knowledgeable. The 
survey assessed for any changes in likelihood that youth would use the app to access information 
on drugs and local treatment resources through the following two questions: After beta testing 
the Granite Connects app, how likely are you to use this app in order to access information on 
drugs? After beta testing the Granite Connects app, how likely are you to use it in order to access 
information on treatment resources in your local area? Likert-type responses ranged from 1 for 
extremely unlikely to 5 for extremely likely. The survey assessed usefulness of the features 
through the following question: After beta testing the Granite Connects app, which feature(s) did 
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you find informative and/or useful? This question allowed for multiple answers, and the choices 
included drug facts and figures, treatment resources, mindfulness activities, education on Narcan, 
warnings related to drug use in your community (e.g., uptick in fentanyl overdoses), ability to 
chat with and ask a medical provider questions, Q&A Forum, and a free-text option. The survey 
assessed satisfaction through the following question: How satisfied are you with the Granite 
Connects app? Likert-type responses ranged from 1 for extremely unsatisfied to 5 for extremely 
satisfied. The survey assessed effectiveness through the following question: How effective is the 
Granite Connects app in providing information on drugs and local resources? Likert-type 
responses ranged from 1 for not effective at all to 5 for extremely effective. The final question 
asked what improvements can be made to the app and allowed for multiple free-text answers.  
Analysis 
 The primary stakeholder focus group took place in-person at GWC Grass Valley location. 
The group sat in chairs arranged in a circle. The questions were verbally posed to the group, and 
each participant verbally responded with an answer. All of the participant responses were 
annotated. The GWConnect team reviewed the transcript and thematically analyzed the data. The 
primary stakeholder survey was distributed online. The intent of the survey was to learn more 
about the primary stakeholders and what they were looking for in an eHealth resource, so the 
data were analyzed both qualitatively and quantitatively. The survey responses were entered into 
Excel and arranged in charts and graphs. The demographic data were depicted in pie charts. 
Microsoft Word was utilized to create a word cloud that depicted the frequency with which the 
respondents used various apps. Thematic analysis was applied to the social media accounts that 
they followed and the overall messages that those accounts were sending, as well as to describe 
the aesthetic of those accounts. 
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 Excel calculated the percentage of respondents who used some sort of mindfulness app. 
Their go-to news-related resources and the ways in which they prefer to learn were arranged in 
bar charts. The respondents ranked substances from most to least commonly used among their 
friends and classmates, and those answers were arranged in a bar chart. Drug-related insight data 
were depicted in a bar chart. Yes/No responses regarding whether or not youth sought out 
information on drugs were depicted in a pie chart. Answers to the follow-up, free-text question 
regarding where they looked or who they asked were listed in a chart. The respondents ranked 
various information related to drugs as either very important, important or not important, and 
that information was depicted in a bar chart. Fears related to drugs were organized in a bar chart. 
The free-text answers regarding use of any informative drug-related resources were listed in a 
chart.  
A Google spreadsheet was utilized to track participation in the pilot program. Qualtrics 
was used to create and distribute the pre- and post-pilot surveys and to collect the qualitative 
data. Qualtrics organized the pre- and post-pilot survey data into tables and either bar or pie 
charts, which were easily exported for visual comparison. The Likert responses were numerically 
ranked from not knowledgeable at all (1) to extremely knowledgeable (5), extremely unlikely (1) 
to extremely likely (5), extremely unsatisfied (1) to extremely satisfied (5), and not effective at all 
(1) to extremely effective (5). The pre- and post-pilot survey responses were analyzed by 
Qualtrics, and the mean percent change, standard deviation, and variance were reviewed to 
determine the effectiveness of the pilot program in increasing knowledge of drugs and local 
treatment resources among the youth who participated. Percentages of satisfaction and app 
effectiveness were calculated. The GWConnect team reviewed all free-text answers regarding 
current and future revisions to the GWConnect app. 
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Ethical Considerations 
The University of San Francisco DNP department determined that this project met the 
guidelines for an evidence-based practice change project, as outlined in the project checklist, and 
was determined to be non-research (see Appendix K). The project received support and 
permission from GWC (see Appendix L). One of the tenets of the GWConnect is user 
confidentiality because it was important to our primary stakeholders and to the GWConnect team 
to create a drug resource that youth can access at any time without fear of being monitored in any 
way. As a result, GWConnect does not collect any personal data. 
This project relates to the Jesuit value of cura personalis or care of the whole person: 
mind, body, and spirit. Preliminary resource and data obtained from the primary stakeholders 
revealed a lack of available resources relevant to all of the stakeholders’ needs. The aim of this 
project was to design and develop a substance use prevention and treatment resource specifically 
for youth, as directed by youth, taking a holistic approach to better meet their mind, body, and 
spiritual needs in a format that they prefer (Ctzejanda, 2019). 
This DNP project relates to the American Nurses Association (ANA, 2015) Code of 
Ethics Provision 1.4 The Right to Self-Determination, which incorporates the ethical principle of 
autonomy. The DNP student recognized that youth have a right to be active, informed 
participants and to direct their care, in so far as the law allows. As a result, youth were engaged 
throughout the entirety of this project. Youth informed the GWConnect team that they 
overwhelmingly prefer a harm reduction versus abstinence-only approach; therefore, this project 
is based upon harm reduction principles. 
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Section IV. Results 
Qualitative data were collected through a primary stakeholder focus group and survey 
prior to the design and development of the GWConnect mobile app. Surveys were also 
administered prior to and after the GWConnect pilot program. The results of the focus group and 
surveys are discussed in detail. 
Youth Focus Group 
An invitation to attend an in-person focus group and provide input on the design of an 
eHealth drug resource was distributed to local high schools in Spring 2020, with 15 attendees 
(eight girls and seven boys). Inclusion criteria was anyone aged 12 to 24 years old residing in 
Nevada or Placer Counties.  
When asked about the language that should be used in the eHealth resource, they advised 
us to: 
• Avoid sounding like a school assignment.  
• “Don’t sound preachy” by avoiding should/should not statements because they did 
not want to be told what is good versus bad. 
• No drug-shaming or overt or covert shaming for using drugs.  
• Include fact-oriented information without any explicit persuasion to not use drugs.  
• Use self-help/mindfulness language.  
• Invite, rather than tell, the user to use the eHealth resource, thereby encouraging 
choice/self-determination.  
• Preferential to pictures versus words.  
When asked how to market this app, they advised us to advertise it in schools and offer 
some sort of monetary incentive to entice people to use it. They referred us to a website, 
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DanceSafe.org, that took a similar approach at a music festival; DanceSafe.org representatives 
offered $100 to each person who visited their website and signed a pledge to not use drugs 
during the music festival.  
When asked about other resources to model this eHealth resource after, they informed 
us of Erowid, Psychoactive Vaults, Welcome to the DMT-Nexus, and GritX. We visited the 
websites and noted that they were easy to navigate, utilized graphics and videos, graphics were 
colorful and enhanced the drug education content, and the language was informative and non-
judgmental.  
Other advice we received was to put an inspirational quote on the Home screen, as well 
as news about drugs, with a link to the full article. They expressed interest in having the 
capability to bookmark articles of interest in a “My Articles” section. They advised us to have a 
searchable dictionary of drugs that includes information on the chemical makeup, dosage, side 
effects, and what the drug does to the body, as well as a lot of pictures of the actual drugs.  
Based on this feedback, the search bar was the first feature we built into the eHealth 
resource, which allows the user to search for anything on the eHealth resource directly from the 
Home screen. The DNP student built the drug data set based upon their feedback and included all 
of the aforementioned information, including pictures of the drugs in their various forms from 
the FDA picture database. The DNP student also researched and uploaded a “How to use 
naloxone” video on the homepage of the app. The GWConnect team is still working on 
incorporating a news ticker that crawls across the Home screen, which would highlight current 
news related to drugs and allow the user to click and access the full article for more information.  
The focus group suggested incorporating mindfulness features, such as breathing/ 
meditation, goal tracking, journaling, or mood tracking. The breathing/meditation feature can 
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include guided meditations, a calming music playlist to choose from, and breathing exercises 
with visual animation. The DNP student researched and recorded a 6-minute body scan 
meditation for inclusion in the mindfulness section of the app.  
The youth advised us that a goal tracker should allow the user to set their own short- and 
long-term goals, create a plan and timeline to complete these goals, and the ability to track their 
progress visually on an appealing graph. The journaling feature should allow for freewriting and 
the option to choose from writing prompts. They would like to look back at past journal entries 
that turn like a page in a book and the ability to customize the whole page with pictures, links, or 
fonts. They would like a mood tracker to pop up when they click on any of the mindfulness 
features; this pop-up should allow them to rate their mood by clicking on an emoji. The user 
should be able to view a graph of their mood over time.   
Additionally, the youth mentioned they would like the eHealth resource to have social 
features that allow them to share pictures or video content with captions similar to the “Story” 
feature on Instagram. Other ideas included: options to remain anonymous or to upload a profile 
photo and to create their own avatar and username. They would like to view popular or famous 
users’ profiles who have personal experiences and stories to tell about drug use, addiction, and 
recovery. Finally, the focus group told us they would like the ability to call a helpline directly 
from the app, to access information on local rehabilitation facilities, and to chat in real-time with 
a live medical practitioner. 
Youth Online Survey 
An online survey was created to gain insight into our primary stakeholders and what they 
were looking for in an eHealth drug resource. Specifically, what information to include in the 
drug info guide and on the map view; how to present the information via text, illustration, video, 
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and audio; and any other input they would like to contribute. The survey was distributed online 
via social media from May 10-14, 2020, and inclusion criteria was anyone 12 years to 24 years 
old residing in the United States. 
There were 28 respondents. All of the respondents were within the desired age range, 
with a fairly even distribution between 15 years and 23 years. Almost 90% of the respondents 
self-identified as female, 7% identified as non-binary/third gender, and only one respondent self-
identified as male. Racial and ethnic data were not collected. Twenty out of 28 respondents lived 
in California. The remainder lived in Maryland, Vermont, Massachusetts, Virginia, Rhode Island, 
and Wisconsin.  
Approximately 35% of respondents felt informed about drugs, their use, and their effects. 
Almost 72% of respondents looked for or asked someone for information about drugs and their 
effects. They searched the internet (7/28), YouTube (1/28), and social media (1/28), and they 
asked their friends (9/28), peers at school (4/28), friends who use drugs (2/28), health teacher 
(1/28), medical professional (1/28), and a parent (1/28).  
The respondents wanted to know the following information about drugs, but were unsure 
where to look or who to ask:  
• drug effects, short- and long-term (4/28); 
• how drugs affect the body and what it feels like (4/28); 
• drug use within the context of harm reduction (3/28); 
• dosages and potency (1/28); and 
• physiological effects of recreational drug use (1/28). 
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The respondents reported the following fears related to drugs: addiction (75%), overdose  
(75%), “bad trip” (60.7%), injury or death (57.1%), getting in trouble with authority figures/ 
parents (42.9%), peer pressure (32.1%), brain fog (3.6%), and nothing (3.6%).  
Youth reported the following information as very important to include in the app: 
duration of drug effects, short- and long-term side effects, interactions with other substances, 
addictive nature, precautions and safety for use, and reversal agents/antidotes. The experience of 
using the drug, photos of drugs, and common street names were important to include, and the 
scientific names of drugs was not important to include in the app.  
The most used substances among our respondents were, in order of usage: marijuana 
(96.4%), alcohol (92.9%), tobacco (46.4%), cocaine (46.4%), hallucinogens (28.6%), and 
prescription drugs (28.6%).  
They have not found any drug- or alcohol-related resources particularly helpful or 
informative (6/28). Two respondents felt their school health class was helpful. Two respondents 
reported searching the internet is helpful. One respondent found the website Reddit informative 
regarding stories about recovery from addiction.  
Youth reported hearing about the news from family (85.7%), friends (82.1%), the 
mainstream media (78.6%), Instagram (67.9%), teachers/other adults (46.4%), TikTok (39.3%), 
Twitter (32.1%), Facebook (21.4%), Tonight with John Oliver (7.1%), and Wikipedia, Reddit, 
LinkedIn, and email news subscriptions (3.6%).  
Youth enjoyed learning about new things by talking with other people (96.4%), watching 
shows/videos (57.1%), reading (46.4%), listening to audio books/podcasts (39.3%), interactive 
activities (e.g., games, quizzes; 28.6%), and watching Tonight with John Oliver (7.1%).  
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The respondents overwhelmingly use video- and photo-based apps the most, with Instagram and 
TikTok tied for the most frequently used. They are also heavily into messaging, via native apps 
and Facebook Messenger. Sixty-four percent downloaded a mindfulness or meditation app, 
usually motivated by an existing need to manage stress or mental health or help with sleep. 
Among social media accounts, there was a mix of relatable celebrities and aspirational 
lifestyles, with a general theme of kookiness, approachability, and honesty. Overall, the tone of 
the accounts was hopeful and confessional. Among the artistic accounts they follow, there was an 
interesting mix of colorful, psychedelic imagery, as well as very simple black and white 
illustration, often used in a narrative format, such as a comic. Many survey respondents showed a 
strong affinity for brands that were sustainable, simple, clear, and also nostalgic. The aesthetic of 
those sites was stark, high-contrast, and relied heavily on colorful products and photography for 
liveliness. 
Pilot Program 
Invitations to participate in the GWConnect pilot program were sent via email in 
February 2021 to the youth focus group participants, youth online survey respondents, Placer and 
Nevada County high school students, and anyone under 25 years who was receiving services at 
GWC. A personalized link to download the GWConnect app for pilot testing was emailed to 
every respondent who completed the pre-pilot survey. The participants were given 80 days to 
interface with the app and advised to provide feedback in the post-pilot survey.  
The pre-pilot survey had 29 respondents, of which 65% resided in Placer County and 
27% resided in Nevada County. The mean age was 17.5 years. Eighty-three percent identified as 
female and 17% identified as male. All of the respondents had access to a mobile device, the vast 
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majority (97%) with an Apple iOS operating system and a small minority (3%) with a Google 
Android operating system.  
 The first question assessed the baseline level of knowledge about drugs, with a mean 
score of 3.0, standard deviation of 0.87, and variance of 0.76. The second question assessed the 
likelihood youth would use a mobile app to access information on drugs, with a mean score of 
3.45, standard deviation of 1.00, and variance of 1.01. The third question assessed baseline 
knowledge of drug treatment resources within their community and how to access them, with a 
mean score of 2.21, standard deviation of 1.03, and variance of 1.06. The final question assessed 
the likelihood youth would use a mobile app to access information on treatment resources in the 
local area, with a baseline mean score of 3.72, standard deviation of 1.23, and variance of 1.51.  
 The post-pilot survey had only 12 respondents, which translates to a 41% completion rate 
for the pilot program. Seventeen individuals were lost to follow-up, despite sending an email 
with clear instructions explaining the pilot program process, multiple follow-up emails, and 
offering an Amazon gift card as an incentive for completion. The mean age of the post-pilot 
survey respondents was 20 years; 83% identified as female and 17% identified as male. Almost 
two-thirds of the participants resided in Placer County and one-quarter resided in Nevada 
County.  
The post-pilot survey demonstrated a 26.47% increase in knowledge about drugs and a 
20.32% increase in likelihood they would use a mobile app to access information on drugs. 
Interestingly, even though the greatest increase was observed in knowledge of drug treatment 
resources and how to access them (45.83%), there was only a slight increase in the likelihood 
they would use a mobile app to access information on treatment resources (14.09%). Results of 
the pre-pilot and post-pilot mean data are displayed in Table 1. 




Survey Q1 Q2 Q3 Q4 
Pre-pilot mean 3.0 3.45 2.21 3.72 
Post-pilot mean 4.08 4.33 4.08 4.33 
% change 26.47 20.32 45.83 14.09 
Note. Q denotes survey question number. 
The level of importance that youth assigned to each app feature in the pre-pilot survey 
correlated with the level of usefulness they reported for each feature in the post-pilot survey. 
These findings indicate that the GWConnect team designed and developed each app feature to 
suit the needs of the primary stakeholders. Results of the pre-pilot data are displayed in Figure 1, 
and results of the post-pilot data are displayed in Figure 2.  
Figure 1 
Importance of Each App Feature 
 
 
DEVELOPMENT OF AN EHEALTH HARM REDUCTION RESOURCE  54 
 
Figure 2 
Usefulness of Each App Feature 
 
Overall, the pilot program participants were satisfied with the GWConnect app, with a 
mean satisfaction score of 4.75, standard deviation of 0.83, and variance of 0.69. They found 
GWConnect to be effective in providing information on drugs and local treatment resources, 
with a mean effective score of 4.58, standard deviation of 0.86, and variance of 0.74. Suggested 
improvements for the app included different colors, layout and navigation by adding more pages, 
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Section V. Discussion 
Summary 
The aim of this project was to design and develop an eHealth drug resource that provided 
culturally-informed harm reduction tools, including unbiased drug information and treatment 
resources, to reduce the overall prevalence of SUD/OUD among rural youth. A pilot program 
was conducted to determine if the app was effective in delivering evidence-based information on 
drug and local treatment resources, if youth were satisfied with the app, and if access to the app 
for up to 80 days resulted in increased knowledge of drugs and treatment resources. The long-
term overarching aim of this project is, by increasing access to this information in a format 
familiar to youth, they will make informed health decisions and seek out help when they need it, 
thereby reducing the incidence of OUD and deleterious health outcomes, such as overdoses.  
Data were collected from youth via an in-person focus group and an online survey in 
order to determine what youth were looking for in an eHealth drug resource. That data informed 
the design and development of GWConnect. Key findings from the focus group included a 
significant emphasis on harm reduction principles and language, unbiased drug information, 
preference towards pictures over words, and the importance of mindfulness features, such as 
meditations. The online survey informed the team that youth wanted access to the following 
information, but were unsure where to look or who to ask: short- and long-term drug effects, how 
drugs affect the body and what it feels like, drug use within the context of harm reduction, 
dosages and potency, and the physiological effects of recreational drug use.  
Interpretation 
The anticipated outcomes of this project included designing and developing an eHealth 
resource based upon harm reduction principles that would engage youth and result in increased 
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knowledge of drugs and treatment resources after an 80-day pilot program. Cordova et al. (2020) 
found that mHealth technology can be used to prevent and reduce health risk behaviors (e.g., 
substance use and unsafe sexual practices) among adolescents. Scheier et al. (2019) gathered 
stakeholder input on the design of an online drug prevention program, and the key findings were 
that the drug prevention content should be presented in an interactive and engaging manner. 
Mobile health resources have been found to engage youth in preventing health risk behaviors, 
specifically drug use (Cordova et al., 2018). The findings of this project are comparative to 
findings from other researchers.  
The youth focus group and online survey data informed the design and development of 
GWConnect. GWConnect was built with four main sections: Home, Information (Info), Help, 
and Map. Advanced nurse practitioners are particularly well-suited for translating the evidence-
based literature for practical application. Therefore, based upon the data collected, the DNP 
student built the evidence-based drug data set for the Info section of the app, utilizing harm 
reduction principles without any particular persuasion towards abstinence, including pictures of 
the drugs in their various forms from the FDA picture database. Commonly abused drugs, such 
as opioids, hallucinogens, stimulants, depressants, and inhalants, were included, and information 
on commercial uses, street names, common forms, short-term effects, long-term effects, health-
related issues, outcomes of mixing with alcohol, and withdrawal symptoms was provided.   
The Home page is the main page, which includes a “How to use naloxone” video that the 
DNP student researched and uploaded. The DNP student, sensitive to primary stakeholder needs, 
also researched and recorded a 6-minute body scan meditation that is accessible on the Home 
page. The Help section offers an opportunity to ask anonymous questions related to substances 
and substance use, and a GWC clinician will provide an answer. The question and corresponding 
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answer will be published for any user to view and reference for their own benefit. The final 
section of the app is a Google maps that has pinned locations for all of the local treatment 
resources in Nevada and Placer Counties.  
Prior to the pilot program, an online survey collected baseline data. Of note, 100% of 
respondents reported having access to a mobile device with either an Apple or Google Android 
operating system. The respondents felt moderately knowledgeable about drugs and slightly 
knowledgeable about treatment resources. They reported being somewhat likely to use a mobile 
app to access information on both drugs and treatment resources. They ranked the app features as 
follows, from most to least important: drug facts and figures, warnings related to drug use in the 
local community (e.g., uptick in fentanyl overdoses), ability to chat with and ask a medical 
provider questions, treatment resources, mindfulness activities, education on Narcan, and Q&A 
forum.   
The pilot program consisted of a personalized link to download the GWConnect app. The 
participants were given 80 days to interface with the app and advised to provide feedback in the 
post-pilot survey. The post-pilot survey demonstrated a 26.47% increase in knowledge about 
drugs and a 45.83% increase in knowledge of treatment resources. One of the most notable 
findings was that the level of importance youth assigned to each app feature in the pre-pilot 
survey correlated with the level of usefulness they reported for each feature in the post-pilot 
survey. These findings indicated that the GWConnect team designed and developed each app 
feature to suit the needs of the primary stakeholders. 
Overall, the pilot program participants were satisfied with the GWConnect app, and they 
found it to be very effective in providing information on drugs and local treatment resources.  
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GWConnect will be published to the Apple and Google app stores as a free download. A 
longitudinal study is recommended to assess app effectiveness related to health risk behaviors, 
specifically substance use and SUDs, among youth.  
Limitations 
The major limitation of this project was the small sample size of participants who 
completed the pilot program. The pre-pilot survey had 29 respondents; however, the post-pilot 
survey had only 12 respondents, which translates to a 41% completion rate for the pilot program. 
Seventeen individuals, accounting for 59% of initial respondents, were lost to follow-up, despite 
sending an email with clear instructions explaining the pilot program process, multiple follow-up 
emails, and offering an Amazon gift card as an incentive for completion.  
Greater than 20% loss to follow-up threatens the validity of the study results (Dettori, 
2011). The various reasons 59% of respondents did not complete the pilot program, albeit 
unknown, can lead to bias among the final results. There is potential that only respondents who 
were satisfied with the app completed the program; whereas, those who were dissatisfied with 
the app did not complete the program.  
Interestingly, the vast majority of the pilot program participants were female. There are 
higher rates of substance use among males versus females; therefore, the gender distribution of 
the sample size is not representative of substance use among the general population (National 
Institute on Drug Abuse, 2021). Follow-up studies with larger sample sizes, more representative 
of the larger population, and more robust follow-up protocols can minimize and adjust for this 
limitation.  
Another expected limitation is related is that GWConnect was designed specifically for 
youth 12 years to 24 years old in Nevada and Placer Counties. As a result, the findings of the 
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pilot program are not generalizable to a larger population. GWConnect will be available for 
anyone to download from the Apple and Google stores; however, future research is needed to 
assess its effectiveness among youth in other geographic locations.  
There were only modest increases in the scores related to the likelihood youth would use 
the mobile app to access information on drugs and treatment resources, indicating room for 
improvement in the app. However, the respondents offered few suggestions for improvement. 
Suggested improvements included changing the colors, increasing the app interactivity, 
improving the layout and usability by adding pages or tabs, and adding more mindfulness 
features.  
The final barrier to implementation is publishing GWConnect to the Apple and Google 
app stores. The app developer will submit GWConnect to the app stores for review, with the 
required fees, and upon approval, the app will be published for free download.  
Conclusions 
Opioid use/misuse is a leading cause of injury and death among adolescents and young 
adults in the United States (Hudgins et al., 2019). Opioid misuse also correlates with misuse of 
other substances, which exponentially increases health risks over time. The most effective 
treatment for OUD among adolescence is through effective prevention interventions that either 
preclude the development of the OUD or enable timely diagnosis and treatment in order to 
prevent poor health outcomes. eHealth technologies have been shown to effectively prevent and 
treat other chronic diseases, and recent research has reported results supporting the use of 
eHealth technologies to prevent and/or treat SUDs among youth (Cordova et al., 2018, 2019, 
2020; Nuamah et al., 2020).  
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Designing and developing eHealth technologies specifically for the management of OUD 
could eliminate a barrier to MAT treatment by allowing the patient the ability to communicate 
with a medical provider, track his or her symptoms, and access evidence-based information and 
reliable resources related to OUD. This technology could be particularly useful among youth due 
to their familiarity with and affinity towards using technology in their everyday lives. 
The pilot program of the eHealth technology, GWConnect, designed and developed in 
this project, found the app to be effective in increasing youth knowledge of drugs and treatment 
resources in their local area and effective in increasing their likelihood of using the app to access 
the aforementioned information. Youth also reported high levels of satisfaction and app 
effectiveness in delivering the information it set out to deliver. GWConnect will now be 
submitted for publication to the Google and Apple app stores as a free download.  
The app was built upon harm reduction, rather than the traditional abstinence-only 
prevention, since research has shown these principles are the most relevant to today’s youth 
(Jenkins et al., 2017). Increased knowledge can empower youth to make informed decisions 
preventing SUD and/or reducing harm related to risky behaviors. Increased knowledge of 
treatment resources can improve timeliness of treatment initiation and reduce harm associated 
with untreated SUD.  
The overarching aim of GWConnect is to reduce the incidence of OUD and overdose 
among rural youth in Northern California; therefore, future longitudinal research is needed to 
assess its effectiveness over a period of time. User data from Google and Apple can also be 
utilized to drive future updates and potentially inform the development of an app that would be 
relevant and applicable to a broader audience.  
 
DEVELOPMENT OF AN EHEALTH HARM REDUCTION RESOURCE  61 
 
Section VI. Other Information 
Funding 
There are no conflicts of interest to disclose. There were no additional outside funding 
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Appendix A. Johns Hopkins Nurse Evidence-Based Evaluation Table 


















sex, and STI/HIV 














data of a mHealth 
resource was 
collected from July 
to September 2015. 
  








asked to fill out a 
demographics 
questionnaire and 




resource on iPads, 
complete modules 
to assess usability, 
and participate in 
either a focus group 
or individual 
interview to discuss 
the overall 
experience.   
 
Pre-assessment data 
revealed that 36% 
of adolescents self-
reported illicit drug 
use within the past 
90 days, and 71% 
of adolescents self-
reported engaging 
in sexual activity 





reported high levels 
of usability and 




that the online risk 
assessment was a 
great way to initiate 
a conversation 
about sensitive 
subjects related to 
health risk 








to be helpful, 
increased their 
knowledge, and 
gave them tools to 





resource to be 
helpful in engaging 
them in preventing 
health risk 
behaviors, 
Level III  
Good Quality 
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to drug use and 










aiming to prevent 












The use of S4E was 
evaluated among 
medical clinicians 
and youth focusing 
on improving the 
communication 
between them, as 




The data suggested 
that S4E facilitated 
communication 
between youth and 
clinicians, as well 
as prevention 
approaches. 
High levels of 
feasibility and 
accessibility were 
reported by both the 
clinicians and the 
youth. 








technology can be 
used to prevent 
and reduce health 
risk behaviors 
(e.g., substance 







evaluated for its 
effect on health 
behavior change 
among youth. S4E 
consists of three 
interactive online 
modules on alcohol 
and drug use, and 
STI/HIV.  
50 youth (13-21 
years) were 
randomized to 
either the S4E arm 
or the standard care 





Youth in the S4E 
arm demonstrated a 
reduction in health 
risk behavior over 
the past 30 days, 
including substance 






technology can be 
utilized to reduce 
substance use and 
other health risk 
behavior among 
youth.  
Level I  
Good Quality  
 










methods study was 
a Phase I 
NIH-funded Small 
Business Innovative 









that the online 
program should 
include the drug 
prevention content 
This study informed 
the design and 
development of 
curriculum for an 
online family-based 
drug prevention 
Level III  
Good Quality  
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person format has 
proven to be 
effective in 
preventing youth 
drug and alcohol 
use, but that 
delivery method 
requires a lot of 




stakeholders in the 
design of the online 
SFP.  
 
They also surveyed 
and conducted 10 
focus groups with 
85 adults.  
in an interactive 
and engaging 
manner.  
There was an 





role play scenarios, 
connection with 
agency personnel 
who can monitor 
progress, and 
printable materials 
to work on at home. 
program based 
upon what the 
family wants to 
learn, in the 
preferred delivery 




retention.   
Schuman-

















of use of MySafeRx 
resource among 




treatment of opioid 






to message your 
medical provider, 
and medication 
monitoring.   
Illicit opioid 
abstinence 
increased by 53% 
during the 28-day 
trial period.  
Participants 
reported good 
levels of usability 
and acceptability of 
the MySafeRx 
technology. 
The MySafeRx, or 
other similar mobile 
technology, can be 
used to increase 
adherence to opioid 
use disorder 
treatment.  
Level III  
Good Quality  
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Development of an eHealth Harm Reduction Resource to Address Opioid Use Among Youth in 
Rural Northern California 
Date May 2021 
Project 
Aim 
The overarching aim is to reduce the incidence of OUD and OD among rural youth in Northern 
California. The project goal is the development and implementation of an eHealth intervention by 
May 2021 that will provide culturally-informed harm reduction tools (e.g., unbiased drug 
information, Narcan information, news alerts, “ask a provider” feature, and referral resources to 
reduce the prevalence of SUD/OUD among rural youth. 
Current State Best Practice Proposed Solution  
Limited knowledge of evidence-
based information on drugs and 
available treatment resources 
resulting in an underserved 
adolescent population with or at-
risk of developing an OUD. 
Access to evidence-based 
information on drugs and available 
treatment resources within a rural 
Northern California community in 
order to improve knowledge about 
drugs and use/misuse, as well as 
awareness of and how to access the 
available treatment resources within 
the local area. 
Design and develop an eHealth 
drug resource specifically for the 
adolescent population within this 
rural Northern California 
community, publish it to the Google 
and Apple store for free download, 
and incorporate it into treatment 
protocols for youth with OUD at 
Granite Wellness.   
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Appendix C. GANTT Chart 
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Appendix D. Work Breakdown Structure 
1.0 Design 
1.1 Develop Project Scope 
1.2 Gap Analysis 
1.3 Develop Objectives 
1.4 Identify Key Stakeholders 
1.5 Develop Project Charter 
1.6 Submit Project Charter 
2.0 Plan 
2.1 Identify Project Team 
2.2 Discussion of Roles 
2.3 Develop Project Plan 
2.4 Develop WBS 
2.5 Develop Focus Group Questionnaire Surveys 
3.0 Intervention 
3.1 Conduct Focus Group 
3.2 Conduct Online Survey 
3.3 Design & Develop Granite Connects App 
3.3.1 Build Evidence-based Drug Data Set 
3.3.1.1 Research 
3.3.1.2 Consult with Personnel Familiar with Harm Reduction Principles  
3.3.2 Record Guided Body Scan 
3.4 Pilot Program  
3.4.1 Administer Pre- and Post-testing Surveys  
4.0 Results 
4.1 Analyze Survey Findings  
4.1.1 Summarize Findings and Write Recommendations 
5.0 Evaluation 
5.1 Review Survey Feedback 
5.2 Write Final Report 
5.3 Dissemination 
5.3.1 DNP Paper 
5.3.2 DNP Presentation 
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DNP Chair and 
Committee Member  
Monthly  Email, Zoom 
DNP project hurdles  DNP Chair As needed Email, Zoom 
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Appendix F. SWOT Analysis 
STRENGTHS 
• The vast majority of youth are familiar with and 
have ready access to mobile technologies. 
• Youth usually have some sort of mobile 
technology with them most of the time making a 
mobile app an ideal intervention to use in this 
population.  
• Mobile technologies have been successfully used 
to prevent and manage other chronic diseases.   
• During the COVID-19 pandemic, people have 
become more reliant on mobile technologies to 
connect virtually due to limitations on in-person 
interactions.  
• Increased knowledge can facilitate informed 
decision making during youth that can prevent 
opioid use disorder.  
• App design and development based upon 
primary stakeholder data obtained via focus 
group and online survey.  
• The app is designed and developed for youth 12-
24 years in Nevada and Placer Counties  
• Funding through the YOR CA grant.  
• Buy-in by the GWC administration. 
WEAKNESSES 
• The app is designed and developed for youth 12-
24 years in Nevada and Placer Counties; Youth 
in other Counties may not find it applicable to 
them.  
• Ability to get youth to download and use the 
app.  
• The app requires a medical provider to answer 
any questions that are asked requiring frequent 
monitoring of the app in order to provide a 
response in a timely manner.  
• The app requires updates regarding news 
related to drugs, use, and warnings in the local 
area.  
• The app will require updates to remain 
compatible with Android and iOS operating 
systems.  








• Initial research revealed that there is not a 
comparable app on the market currently.  
• Primary stakeholders reported what they were 
looking for in an eHealth resource through the 
focus group and online survey, and that data 
gave the team the opportunity to design and 
develop the app specifically for the primary 
stakeholders.  
• Opportunity to connect with youth in a medium 
that they prefer, are familiar with, and have 
ready access to.  
• Ability to remain connected with youth even 
during the COVID-19 pandemic when in-person 
interactions are limited.  
• Youth will have the opportunity to access 
evidenced-based information on drugs, 
treatment resources, and ask a medical provider 
questions in a secure, confidential, and non-
confrontational manner.   
• Dispel common myths about drugs and drug 
use.  
• Prevent OUD amongst youth in Northern 
California.  
THREATS 
• App buy-in by youth.  
• Youth may have a fear that their 
parents/guardians or the app administrator(s) 
are monitoring their activity, and simply 
accessing drug information could be perceived 
as thinking about or actually using drugs.    
• Parents/guardians having a misperception that 
allowing youth to access information will make 
them more apt to use drugs.  
• Concern that the YOR CA grant funding may 
not be renewed.  
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Appendix G. 3-Year Proforma 
Design, Development, Distribution, and 
Maintenance of GWConnect 
      
  Year 1 Year 2 Year 3 
Grant Funding $500,000 $515,000  $530,450  
Deductions from Revenue 0 0 0 
Total revenue $500,000 $515,000 $530,450 
        
NP wages (0.5 NP FTE) $56,737  $58,439  $60,192  
App Design & Development  
(0.5 App Developer FTE in Years 2 & 3)  
$25,000  $36,987  $38,096  
Total wages $81,737 $95,426 $98,288 
Supplies $100 $103 $106 
Total Expenses $81,837 $95,529 $98,394  
        
Revenue less expenses $418,163 $419,471  $432,056 
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Appendix H. Return on Investment Analysis 







($81,837) $1.3 million per fatal 
overdose 
$1.2 million 
($81,837) $176.8 million fatal 
overdoses per day 
$176.7 million 
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Appendix I. Pre-Pilot Program User Survey 
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Appendix J. Post-Pilot Program User Survey 
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Appendix K. DNP Statement of Non-Research Determination Form 
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Appendix L. Letter of Support 
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Appendix M. Youth Focus Group Findings 
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Appendix N. Youth Online Survey 
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Appendix O. Youth Online Survey Findings 
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Appendix P. Drug Database 
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Appendix Q. Example of Harm Reduction Principal Application 
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Appendix R. Body Scan Script for the Mindfulness Section 
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Appendix S. GWConnect Home Section 
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Appendix T. GWConnect Drug Info Section 
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Appendix U. GWConnect Map Section 
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Appendix V. GWConnect Help Section 
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Appendix W. Pre-Pilot Survey Findings 
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Appendix X. Post-Pilot Survey Findings 
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